BIO Deutschland English News ’s Post

After kicking off November at the Meet the XLEAP workshop in Prague, my next stop was Bratislava! Last week I had the pleasure of joining my Slovak colleagues from GeneTiCA Group to meet experts from MEDIREX GROUP and MEDIXBANK, where we explored the future of laboratory automation and its potential impact on their work. It was a fantastic opportunity to showcase the 𝐆𝐞𝐧𝐞𝐓𝐢𝐂𝐀 𝐄𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞 𝐂𝐞𝐧𝐭𝐫𝐞 and discuss how automation is transforming laboratories and bringing them into the 21st century. 🚀 𝐖𝐡𝐲 𝐚𝐮𝐭𝐨𝐦𝐚𝐭𝐞? It's not just about the high-tech appeal (although it certainly makes the lab look cool!); it's about freeing teams from repetitive tasks, such as NGS library preparation or nucleic acid isolation, that can be prone to costly errors if attention lapses for a moment. By automating these workflows, we can secure valuable samples, reduce errors and save significant time and resources. 🧪🕐 The Illumina TruSight Oncology 500 (TSO 500) assay is a great example. This NGS-based CGP workflow takes around 𝟏𝟎.𝟓 𝐡𝐨𝐮𝐫𝐬 manually, but automation 𝐜𝐮𝐭𝐬 𝐭𝐡𝐚𝐭 𝐝𝐨𝐰𝐧 𝐭𝐨 𝟐.𝟓 𝐡𝐨𝐮𝐫𝐬. That's time saved for high-impact work like data analysis and clinical interpretation, turning routine tasks into meaningful research that drives discovery. 👩🔬👨🔬 If you're curious about advancing your lab workflows through automation, let's connect and explore custom solutions together! #GeneTiCA #GetToKnow #GeneTiCAExperienceCentre #Automation #InnovationInMultiOmics

⏰ In about one hour! Join us to hear about the latest updates to our Chemistry42 #generativeAI platform for small molecule design and optimization! Including: #hitID workflows Multi-Parametric #LeadOPT #BindingFreeEnergy predictions #ADMET profile prediction, optimization and model training #Retrosynthesis ...and so much more!

Webinar covering the new version of Chemistry42 and its key features is going live very soon!

📢 🔥 Partnership announcement 🔥📢 Excited to share that that we've joined forces with Agilent Technologies to build the next generation of analytical tools. ❄️ The Isospec / Agilent instrument will be the first implementation of CIRIS technology in one of the most powerful mass spectrometers on the market. 🤝 This partnership marks a crucial milestone in enabling biomarker discovery at an unprecedented scale, consolidating Isospec's pioneering position in pushing the boundaries of human health research. The official press release can be found here: https://lnkd.in/dDi-dATK

Looking forward to talking about our efforts on cancer drug discovery using single-cell omics and AI

The results of R.PRJ are available on bioRxiv demonstrating the reproducibility of Sampling Human’s technology for the highly specific capture of single cells for analysis. Decentralized data collection by independent labs was made possible by our uniquely user-friendly benchtop kit. Key takeaways - 78 assays were conducted by 30 users across 12 distinct laboratories, demonstrating high reproducibility and sensitivity. - First-time users from diverse laboratory environments and proficiency levels were able to consistently discriminate between sample types differing only by 0.001%. - Target cells were accurately identified at concentrations as low as 1 cell per 100,000 background cells. Read the article here: https://lnkd.in/e7jen3Cz

👋 Hope to see you at Vitalis in May. I will give a talk on AI and share detailed insights into the most interesting early-stage life science projects in the Nordic region and how AI connects life science and technology. These early stage companies, together with the existing ecosystem, will play a significant role in shaping the future of healthcare. A clear trend is that the boundaries between pharmaceuticals, medical technology, and e-health are gradually fading. Two particularly interesting additions to the matrix are AI and advanced materials, which, when combined, create impressive technological leaps. Pin Tuesday May 14, 2024 14:30 in your cal 😊 Scale Up Life Science Invest, magnus klaesson, Ann-Charlotte Beckman, Nasim Bergman Farrokhnia, Gunilla Englund, Karina Tellinger McNeil, Daniel Forslund, Boel Mörck, Mikael Hoffmann, Karin Gårdmark Östh, Björn Arvidsson

🌟 Phenotypic drug discovery has delivered transformative therapies—but are we at the start of a new wave or nearing the end of an era? Will emerging tools like AI and advanced imaging, coupled with market shifts like increased open innovation, elevate phenotypic drug discovery to new heights? Or will the high costs of automation limit new players, and cellular models fall short in clinical translation? Share your perspective in an anonymous 3-minute survey on the future of phenotypic drug discovery 🔗 https://lnkd.in/es2Snj7P Results will be unveiled during the Future of Phenotypic Drug Discovery panel at #SLAS2025 in San Diego—and shared with the broader community afterward on LinkedIn. If you're attending SLAS2025 in San Diego, I'll be chairing a panel the morning of January 28th that brings together leaders in Phenotypic Drug Discovery, to discuss where the field is headed. Comment below to learn more or you'd like to meet up at SLAS! #DrugDiscovery #PhenotypicScreening #InnovationInScience #AIInBiotech #SLAS2025 #LifeSciences

Grateful for the opportunity to participate in the 2024 CAP TODAY Urinalysis Roundtable. It was both a critical and illuminating discussion on the current state of testing. The future is bright for urinalysis as Siemens Healthineers and clinical laboratory leaders aim to overcome challenges and expand in-vitro diagnostic opportunities through tools such as digitalization and AI! Read now. https://lnkd.in/e_fuqsx5

ELITechGroup - A Bruker Company 🌟 Product Highlight: Elitech Group’s Elite BeGenius 🌟 In the ever-evolving world of molecular diagnostics, having the right tools can make all the difference. The Elite BeGenius by Elitech Group is designed to empower laboratories with state-of-the-art automation and precision, pushing the boundaries of what's possible in molecular testing. Here’s why the Elite BeGenius stands out: ✅ Fully automated PCR workflow, from sample preparation to results interpretation, improving lab efficiency and reducing human error. ✅ High-throughput capability, allowing simultaneous processing of up to 48 samples, making it ideal for labs dealing with high volumes. ✅ Flexible, multipurpose design, capable of handling various assays—from infectious diseases to genetic testing—ensuring labs stay versatile. ✅ Compact and space-efficient, the Elite BeGenius fits seamlessly into any lab environment without sacrificing performance. By incorporating the Elite BeGenius, labs can experience faster turnaround times, increased accuracy, and the ability to scale operations to meet growing demands. 🔗 How has automation changed your approach to molecular diagnostics? Let’s discuss how technologies like Elite BeGenius are shaping the future of lab testing. #ProductHighlight #ElitechGroup #EliteBeGenius #MolecularDiagnostics #Automation #PCR #LabInnovation #HealthcareTech #Laboratory